Back to search

Article

Empagliflozin's role in reducing ventricular repolarization heterogeneity: Insights into cardiovascular mortality decline from the EMPATHY-HEART trial

2024-04-03

Abstract excerpt

<h4>Background: </h4> The incidence of myocardial infarction (MI) and sudden cardiac death (SCD) is significantly higher in individuals with Type 2 Diabetes Mellitus (T2DM) than in the general population. Strategies for the prevention of fatal arrhythmias are often insufficient, highlighting the need for additional non-invasive diagnostic tools. The T-wave heterogeneity (TWH) index measures variations in ventricul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a23ed695-f962-597b-a313-d880b75c2e7a
DOI
10.21203/rs.3.rs-4183475/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Empagliflozin's role in reducing ventricular repolarization heterogeneity: Insights into cardiovascular mortality decline from the EMPATHY-HEART trialDOI 10.21203/rs.3.rs-4183475/v1
Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype.Semantic proximity
Genome-Wide Associations of Global Electrical Heterogeneity ECG Phenotype: The ARIC (Atherosclerosis Risk in Communities) Study and CHS (Cardiovascular Health Study).Semantic proximity
Ventricular remodeling with dapagliflozin in elderly women with HFpEF--a single center prospective studySemantic proximity
Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial.Semantic proximity
Competing Risks in Patients with Primary Prevention Implantable Cardioverters Defibrillators: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) StudySemantic proximity
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudySemantic proximity
Cardiovascular drugs approved for heart failure with reduced ejection fraction and/or post-myocardial infarction exert consistent effects in both populations: A meta-analysis and meta-regression of randomized controlled trialsSemantic proximity
Glycaemic variability underlies myocyte dysfunction and myocardial injury risk in diabetesSemantic proximity
Differences in Repolarization Heterogeneity Among Heart Failure With Preserved Ejection Fraction Phenotypic Subgroups.Semantic proximity
Common Genetic Variants Modulate the Electrocardiographic Tpeak-to-Tend Interval.Semantic proximity
Proton Pump Inhibitors and Cardiac Safety: Emerging Evidence Linking Cardiovascular Disease, Arrhythmias, and Mechanistic PathwaysSemantic proximity
Myocyte Enhancer Factor-2A Gene Mutation and Coronary Artery Disease.Semantic proximity
Select a neighboring publication to make it the new centre.